Fig. 3From: Corticosteroid treatment in severe patients with SARS-CoV-2 and chronic HBV co-infection: a retrospective multicenter studySubgroup analysis of 28-day mortality according to corticosteroid therapy in patients with severe COVID-19 and HBV co-infection. COVID-19: coronavirus disease 2019; HBV: hepatitis B virus; Hs-CRP: high sensitive c reaction protein; RR: risk ratio; CI: confidence intervalBack to article page